BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shah RR, Gaedigk A. Precision medicine: does ethnicity information complement genotype-based prescribing decisions? Ther Adv Drug Saf 2018;9:45-62. [PMID: 29318005 DOI: 10.1177/2042098617743393] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Ntekim A, Olopade OI. Innovative Strategies for Developing Biomarker-Informed Cancer Clinical Trials to Accelerate Progress in Precision Oncology in Sub-Saharan Africa. Am Soc Clin Oncol Educ Book 2022;42:1-9. [PMID: 35687824 DOI: 10.1200/EDBK_349955] [Reference Citation Analysis]
2 Akuffo-Addo E, Udounwa T, Chan J, Cauchi L. Exploring Biologic Treatment Hesitancy Among Black and Indigenous Populations in Canada: a Review. J Racial Ethn Health Disparities 2022. [PMID: 35476223 DOI: 10.1007/s40615-022-01282-x] [Reference Citation Analysis]
3 Reddy VD, Myers BA, Chan SY, Thibodeaux QG, Brownstone ND, Bhutani T, Liao W, Lester JC, Koo JY. A review of current phase III clinical trials of plaque psoriasis: under-representation of nonwhite participants and need for reform. Br J Dermatol 2021;184:348-50. [PMID: 32767747 DOI: 10.1111/bjd.19468] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lin YS, Thummel KE, Thompson BD, Totah RA, Cho CW. Sources of Interindividual Variability. Methods Mol Biol 2021;2342:481-550. [PMID: 34272705 DOI: 10.1007/978-1-0716-1554-6_17] [Reference Citation Analysis]
5 Chiarella P, Capone P, Carbonari D, Sisto R. A Predictive Model Assessing Genetic Susceptibility Risk at Workplace. Int J Environ Res Public Health 2019;16:E2012. [PMID: 31195756 DOI: 10.3390/ijerph16112012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
6 Ciebiera M, Ali M, Zgliczyńska M, Skrzypczak M, Al-Hendy A. Vitamins and Uterine Fibroids: Current Data on Pathophysiology and Possible Clinical Relevance. Int J Mol Sci 2020;21:E5528. [PMID: 32752274 DOI: 10.3390/ijms21155528] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
7 Neyshaburinezhad N, Rouini MR, Entezari H, Lavasani H, Hosseinzadeh Ardakani Y. Evaluation of changes in cytochrome P450 2C19 activity in type 2 diabetic rats before and after treatment, by using isolated perfused liver model. Iran J Basic Med Sci 2020;23:629-35. [PMID: 32742601 DOI: 10.22038/ijbms.2020.40836.9642] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Petrkova J, Taborsky M, Petrek M. Pharmacogenetics of Cardiovascular Disease: Genetic Variation and Statin Intolerance. In: Liu Y, editor. Genetic Diversity and Disease Susceptibility. InTech; 2018. [DOI: 10.5772/intechopen.79518] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Zgheib NK, Patrinos GP, Akika R, Mahfouz R. Precision Medicine in Low‐ and Middle‐Income Countries. Clin Pharmacol Ther 2019;107:29-32. [DOI: 10.1002/cpt.1649] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
10 Shea L, Pesa J, Geonnotti G, Powell V, Kahn C, Peters W. Improving diversity in study participation: Patient perspectives on barriers, racial differences and the role of communities. Health Expect 2022. [PMID: 35765232 DOI: 10.1111/hex.13554] [Reference Citation Analysis]
11 Cacabelos R. Population-level pharmacogenomics for precision drug development in dementia. Expert Review of Precision Medicine and Drug Development 2018;3:163-88. [DOI: 10.1080/23808993.2018.1468218] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
12 Carr DF, Turner RM, Pirmohamed M. Pharmacogenomics of anticancer drugs: Personalising the choice and dose to manage drug response. Br J Clin Pharmacol 2021;87:237-55. [PMID: 32501544 DOI: 10.1111/bcp.14407] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Koopmans AB, Braakman MH, Vinkers DJ, Hoek HW, van Harten PN. Meta-analysis of probability estimates of worldwide variation of CYP2D6 and CYP2C19. Transl Psychiatry 2021;11:141. [PMID: 33627619 DOI: 10.1038/s41398-020-01129-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
14 Lazorwitz A, Aquilante CL, Shortt JA, Sheeder J, Teal S, Gignoux CR. Applicability of ancestral genotyping in pharmacogenomic research with hormonal contraception. Clin Transl Sci 2021;14:1713-8. [PMID: 33650294 DOI: 10.1111/cts.13014] [Reference Citation Analysis]
15 Gill PS, Elchynski AL, Porter-gill PA, Goodson BG, Scott MA, Lipinski D, Seay A, Kehn C, Balmakund T, Schaefer GB. Multidisciplinary Consulting Team for Complicated Cases of Neurodevelopmental and Neurobehavioral Disorders: Assessing the Opportunities and Challenges of Integrating Pharmacogenomics into a Team Setting. JPM 2022;12:599. [DOI: 10.3390/jpm12040599] [Reference Citation Analysis]
16 Tukur UM, Bello SO. Gender Variations in Pharmacokinetics of Paracetamol in Hausa/Fulani Ethnic group in Northwest Nigeria - A Two-stage Approach. Int J Appl Basic Med Res 2021;11:248-52. [PMID: 34912689 DOI: 10.4103/ijabmr.ijabmr_144_21] [Reference Citation Analysis]
17 Jagtap S, Sowmithra, Yadav R, Pal PK, Datta I. Generation of induced pluripotent stem cells (NIMHi004-A, NIMHi005-A and NIMHi006-A) from healthy individuals of Indian ethnicity with no mutation for Parkinson’s disease related genes. Stem Cell Research 2022;60:102716. [DOI: 10.1016/j.scr.2022.102716] [Reference Citation Analysis]
18 Tavares LC, Marcatto LR, Santos PCJL. Genotype-guided warfarin therapy: current status. Pharmacogenomics 2018;19:667-85. [PMID: 29701078 DOI: 10.2217/pgs-2017-0207] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
19 Neyshaburinezhad N, Rouini M, Shirzad N, Esteghamati A, Nakhjavani M, Namazi S, Ardakani YH. Evaluating the effect of type 2 diabetes mellitus on CYP450 enzymes and P-gp activities, before and after glycemic control: A protocol for a case-control pharmacokinetic study. MethodsX 2020;7:100853. [PMID: 32337164 DOI: 10.1016/j.mex.2020.100853] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
20 Afsar NA, Bruckmueller H, Werk AN, Nisar MK, Ahmad HR, Cascorbi I. Implications of genetic variation of common Drug Metabolizing Enzymes and ABC Transporters among the Pakistani Population. Sci Rep 2019;9:7323. [PMID: 31086207 DOI: 10.1038/s41598-019-43736-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
21 Rajman I, Pasqua OD; Joint Steering Committee Africa GRADIENT. Introducing Project Africa GRADIENT. Drug Discov Today 2019;24:2229-30. [PMID: 31693869 DOI: 10.1016/j.drudis.2019.10.010] [Reference Citation Analysis]
22 van Hoogdalem EJ, Jones Iii JP, Constant J, Achira M. Science-based Ethnic Bridging in Drug Development; Review of Recent Precedence and Suggested Steps Forward. Curr Clin Pharmacol 2019;14:197-207. [PMID: 30961506 DOI: 10.2174/1574884714666190408125206] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Yuan G, Wang L, Li J, Feng H, Ji J, Gu W, Shan B. Complexity in Clinical Trials: Blind Spots, Misleading Criteria, Winners and Losers. CCAND 2020;7:3-15. [DOI: 10.2174/2212697x06666191021125423] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Tolentino-Hernández SJ, Cruz-Antonio L, Pérez-Urizar J, Cabrera-Fuentes HA, Castañeda-Hernández G. Oral Ciprofloxacin Pharmacokinetics in Healthy Mexican Volunteers and Other Populations: Is There Interethnic Variability? Arch Med Res 2020;51:268-77. [PMID: 32143939 DOI: 10.1016/j.arcmed.2020.02.008] [Reference Citation Analysis]
25 Mirzaev K, Abdullaev S, Akmalova K, Sozaeva J, Grishina E, Shuev G, Bolieva L, Sozaeva M, Zhuchkova S, Gimaldinova N, Sidukova E, Serebrova S, Asoskova A, Shein A, Poptsova M, Suleymanov S, Burashnikova I, Shikaleva A, Kachanova A, Fedorinov D, Sychev D. Interethnic differences in the prevalence of main cardiovascular pharmacogenetic biomarkers. Pharmacogenomics 2020;21:677-94. [DOI: 10.2217/pgs-2020-0005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
26 Kolesar J, Peh S, Thomas L, Baburaj G, Mukherjee N, Kantamneni R, Lewis S, Pai A, Udupa KS, Kumar An N, Rangnekar VM, Rao M. Integration of liquid biopsy and pharmacogenomics for precision therapy of EGFR mutant and resistant lung cancers. Mol Cancer 2022;21:61. [PMID: 35209919 DOI: 10.1186/s12943-022-01534-8] [Reference Citation Analysis]
27 Duconge J, Santiago E, Hernandez-Suarez DF, Moneró M, López-Reyes A, Rosario M, Renta JY, González P, Ileana Fernández-Morales L, Antonio Vélez-Figueroa L, Arce O, Marín-Maldonado F, Nuñez H, Melin K, Scott SA, Ruaño G. Pharmacogenomic polygenic risk score for clopidogrel responsiveness among Caribbean Hispanics: A candidate gene approach. Clin Transl Sci 2021. [PMID: 34415683 DOI: 10.1111/cts.13124] [Reference Citation Analysis]
28 Shah RR. Genotype‐guided warfarin therapy: Still of only questionable value two decades on. J Clin Pharm Ther 2020;45:547-60. [DOI: 10.1111/jcpt.13127] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
29 Rajman I, Knapp L, Hanna I. Genetic Diversity in Drug Transporters: Impact in African Populations. Clin Transl Sci 2020;13:848-60. [PMID: 32100958 DOI: 10.1111/cts.12769] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
30 Crutchley RD, Keuler N. Sub-Analysis of CYP-GUIDES Data: Assessing the Prevalence and Impact of Drug-Gene Interactions in an Ethnically Diverse Cohort of Depressed Individuals. Front Pharmacol 2022;13:884213. [DOI: 10.3389/fphar.2022.884213] [Reference Citation Analysis]